Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome.
about
A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injuryBusulphan-cyclophosphamide cause endothelial injury, remodeling of resistance arteries and enhanced expression of endothelial nitric oxide synthaseThrombotic thrombocytopenic purpura and hemolytic uremic syndrome following allogeneic bone marrow transplantation.Association of Helicobacter pylori with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome after bone marrow transplantation.Intestinal damage determines the inflammatory response and early complications in patients receiving conditioning for a stem cell transplantationSerum stem cell growth factor for monitoring hematopoietic recovery following stem cell transplantation.Engraftment syndrome following hematopoietic stem cell transplantation.Blockade of Vascular Endothelial Growth Factor (VEGF) Aggravates the Severity of Acute Graft-versus-host Disease (GVHD) after Experimental Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)The potential role of lactoferrin and derivatives in the management of infectious and inflammatory complications of hematology patients receiving a hematopoietic stem cell transplantation.Nutritional support in patients with GVHD of the digestive tract: state of the art.Mucosal barrier injury, fever and infection in neutropenic patients with cancer: introducing the paradigm febrile mucositis.Engraftment syndrome: double-edged sword of hematopoietic cell transplants.Local and systemic pathogenesis and consequences of regimen-induced inflammatory responses in patients with head and neck cancer receiving chemoradiation.An autopsy case that manifested no convincing histological changes of severe renal failure after hematopoietic stem cell transplantation.Engraftment syndrome after allogeneic hematopoietic cell transplantation in adults.The clinical value of biomarkers in respiratory complications in hematopoietic SCT.Clinical impact of hyperacute graft-versus-host disease on results of allogeneic stem cell transplantation.Gram-negative bacteraemia (GNB) after 428 unrelated donor bone marrow transplants (UD-BMT): risk factors, prophylaxis, therapy and outcome.Engraftment syndrome in children undergoing autologous peripheral blood progenitor cell transplantation.Cytokines and Cytomegalovirus Disease Following Allogeneic Bone Marrow Transplantation.Early-onset acute kidney injury is a poor prognostic sign for allogeneic SCT recipients.Human leukocyte antigen DR surface expression on CD14+ monocytes during adverse events after hematopoietic stem cell transplantation.Selenium supplementation in patients undergoing hematopoietic stem cell transplantation: effects on pro-inflammatory cytokines levels.Adaptive Immune Response Impairs the Efficacy of Autologous Transplantation of Engineered Stem Cells in Dystrophic Dogs.Oral eicosapentaenoic acid for complications of bone marrow transplantation.Endothelial damage caused by cytomegalovirus and human herpesvirus-6.Prognostic value of cyclic GMP in patients undergoing allogeneic bone marrow transplantation after conditioning with total body irradiation.A rare case of interstitial pneumonitis after tandem high-dose melphalan conditioning and autologous stem cell transplantation in multiple myeloma.Differential effect of conditioning regimens on cytokine responses during allogeneic stem cell transplantation.Coordinated responses of natural anticoagulants to allogeneic stem cell transplantation and acute GVHD - A longitudinal study.Risk factors of human herpesvirus 6 encephalitis/myelitis after allogeneic hematopoietic stem cell transplantation.Correlations of HHV-6 viral load and plasma IL-6 concentration with HHV-6 encephalitis in allogeneic stem cell transplant recipients.Organ dysfunction following stem cell transplantation: relationship to plasma cytokine concentrations.New-onset microalbuminuria following allogeneic myeloablative SCT is a sign of near-term decrease in renal function.Serum elastase and antithrombin-3 in patients with acute graft-vs.-host disease after bone marrow transplantation.VEGF165 attenuates the Th17/Treg imbalance that exists when transplanting allogeneic skeletal myoblasts to treat acute myocardial infarction.
P2860
Q26992169-E50B2944-2101-4E84-B520-27F99447AAF5Q28732371-CDA24743-1F26-42E6-8377-82A58A855588Q33342975-A009E7B8-ECA6-4502-9407-87754E24A387Q33362425-DD95F6B4-1BF4-42C8-90DB-25457B7AA5A4Q33781213-4E41DA6B-0D9E-417C-BEE0-B3C085995C39Q34219953-D73E8D4D-16CF-4ED3-B20E-87C2673196ACQ34298239-C886B185-2AB7-4AC6-B58B-A514A8008355Q35745507-F712E069-1754-4C95-A231-60100401B1EDQ36867429-184BDF2A-673D-49F0-9A4D-75B2D86C4DBBQ38024717-DC22146B-6F7A-4DB4-8A43-5FE0A0299435Q38246766-96601CCA-9592-47FB-928A-BE28C4DA0FACQ38315390-8D3064F1-2818-4517-BB19-BA08ACBC0457Q38625302-5DF72BAC-2EC5-45BF-A02C-7DD354BF20CDQ38783688-8739C2EF-FB48-49C8-BB16-9C1E2AA4C617Q39222708-DA3D935C-D479-48A1-97BF-1B6BD00E0223Q40474709-F43E2DEE-44E1-4651-AC82-E6AA27B267A9Q40536686-A225E7D2-A09D-4E7D-B082-37F3CC63B671Q40545180-10C20E13-5772-4B9F-A5C1-FCDF94999BE5Q40574813-628D940F-53BD-4C3F-A46A-EF6BC6A8FA80Q40610275-0695D604-F3CC-4D0A-B461-EEB0538D37F1Q41457542-B941C020-8E1C-48E2-8D7A-D10111634735Q42200652-541C2745-2DE1-4445-A8A9-3F9353C22FC4Q42716642-97D3BA4C-3455-4DA5-8C1C-06173FB9A922Q42859445-CA62E79C-A065-46B8-8A28-F724B634971FQ43848102-B7164B9E-7E6D-46E5-B87B-199C4E167DF2Q44383243-E925BF59-75C1-4E44-BD09-7630B9F3AC0DQ44442087-3D57E719-C32B-4E17-BDBC-8C31F5D1372EQ44971633-CCA09966-9760-4F3F-AE9E-C84F8725CAB0Q46941346-FBCD859F-D7EA-459B-90C5-4AFDAFC64315Q47260653-0D037F5E-FA6F-4998-949F-472E72516277Q47436824-E9F19070-7873-4200-B696-41A6E11B30B9Q47733733-2D96B4F7-341E-4680-82C4-027AEF81DF3AQ51960835-1F1012F0-A785-4123-AAF4-50EF0442B4BFQ53124728-DE7F5C2F-BBE3-432B-873E-DC1F1F59795CQ53666951-7F347B8F-7FD2-47DD-8359-F1F678A75E93Q54291226-B0E59868-B34C-4F27-9CB4-318487EB2ADF
P2860
Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Complications after bone marro ...... nflammatory response syndrome.
@en
type
label
Complications after bone marro ...... nflammatory response syndrome.
@en
prefLabel
Complications after bone marro ...... nflammatory response syndrome.
@en
P2093
P356
P1476
Complications after bone marro ...... nflammatory response syndrome.
@en
P2093
Fujimori Y
Kakishita E
Kanamaru A
Takatsuka H
Takemoto Y
P2888
P304
P356
10.1038/SJ.BMT.1702517
P407
P577
2000-08-01T00:00:00Z
P5875
P6179
1017666086